Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.

Eur J Clin Microbiol Infect Dis · 2021 · PMC8189710 · PMID 34109500

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

Comparison of means showed a trend towards higher Vircell-IgM/A antibody indices for samples from patients with Coronavirus NL63 (p = 0.08) or Mycoplasma pneumoniae (p = 0.07) infections.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.